MedPath

An fMRI and EEG study in patients with mild to moderate Alzheimer’s disease and healthy elderly controls

Conditions
Alzheimer's disease, healthy volunteers, biomarker
Registration Number
NL-OMON21111
Lead Sponsor
Centre for Human Drug Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

All subjects:

1.Aged 50-75 years;

Exclusion Criteria

All subjects:

1.Any contra-indications for MRI (prostheses, implants, claustrophobia, pacemakers, etc.);

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fMRI memory task - BOLD activity<br /><br>fMRI perception task - BOLD activity<br /><br>EEG based technique to measure longterm potentiation- amplitudes and latencies<br /><br>auditory steady state response - gamma oscillations<br />
Secondary Outcome Measures
NameTimeMethod
fMRI resting state - default mode network<br /><br>Evoked related potentials - amplitude and latencies
© Copyright 2025. All Rights Reserved by MedPath